By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MagForce AG 

Max-Planck-Strasse 3
Haus 5.2
Berlin    12489   Germany
Phone: 49-30-3083800 Fax: 49-30-30838099


Company News
MagForce AG: Magforce USA, Inc. Files Investigational Device Exemption For Nanotherm Therapy To Treat Intermediate Risk Prostate Cancer 5/21/2015 9:43:14 AM
MagForce AG Announces That Cologne University Hospital Has Initiated Commercial NanoTherm Treatments For Brain Cancer 5/7/2015 10:57:55 AM
MagForce AG Announces That Kiel University Hospital (UKSH) Has Initiated Commercial NanoTherm Treatment For Brain Cancer 3/27/2015 11:26:48 AM
MagForce AG Installs NanoActivator At The Cologne University Hospital 3/23/2015 1:00:17 PM
MagForce AG Publishes Its First Shareholder Letter 2015 2/5/2015 9:17:41 AM
MagForce AG And Magforce USA, Inc. Announce FDA Pre-IDE Meeting On Magforce's Nanotherm™ Prostate Cancer Therapy Pre-Submission 1/27/2015 9:54:50 AM
MagForce AG Publishes Its Fourth Shareholder Letter 2014 11/12/2014 2:04:27 PM
MagForce AG: MagForce USA, Inc. Announces The Filing Of A Pre-Submission For MagForce's NanoTherm™ Focal Therapy For Intermediate Risk Prostate Cancer 11/11/2014 9:11:03 AM
MagForce AG Announces Positive Results Of 2014 Annual General Meeting 8/19/2014 9:45:10 AM
MagForce AG Publishes Financial Results For The First Half Of 2014 And Operative Highlights 8/14/2014 1:59:49 PM